Susquehanna International Group
TNGX icon

Susquehanna International Group’s Tango Therapeutics TNGX Stock Holding History

Susquehanna International Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$699K Buy
+33,400
New +$465K ﹤0.01% 8816
2025
Q4 		– Sell
-14,300
Closed -$120K – 13631
2025
Q3 		$120K Buy
+14,300
New +$96.8K ﹤0.01% 11449

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Susquehanna International Group's TNGX Position: Q1 2026 in Review

Susquehanna International Group increased its Tango Therapeutics (TNGX) stake by 145% in Q1 2026, buying an estimated $712K and bringing the position to 86,350 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #6406.

Susquehanna International Group first reported a position in TNGX in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.52M in Q1 2022. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Susquehanna International Group held 86,350 shares of Tango Therapeutics worth $1.81M as of Q1 2026.
  • Susquehanna International Group bought 51,134 Tango Therapeutics shares in Q1 2026, an estimated $712K.
  • Tango Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6406 holding.
  • Susquehanna International Group first reported a position in Tango Therapeutics in Q4 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Tango Therapeutics position peaked at $2.52M in Q1 2022.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.